Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7622
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) is engaged in the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw materials and preparations, bio-engineering drugs, and nutritious and health products. Its product portfolio includes suxiao jiuxin wan, ticlopidine hydrochloride tablets, cold soft capsules, verapamil hydrochloride tablets, anti-bone hyperplasia pill, pregnant women jinhua tablets, and diarrhea and sputum tablets, and others. TZPG also conducts research and development to develop new pharmaceutical products. The company’s products are used to treat cardiovascular disease, cold, vomit, diarrhea, dyspepsia, chemotherapy, diabetes, skin diseases, gastrointestinal and pneumonia. TZPG is headquartered in Tianjin, China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tianjin Zhongxin Pharma To Form Two Joint Ventures 10
Equity Offering 11
Tianjin Zhongxin Raises USD135.6 Million in Private Placement of Shares 11
Acquisition 13
Jiaxing Yun Shi Tai Yu Investment to Acquire 20% Stake in Tianjin Sinobioway Biomedicine from Tianjin Zhongxin Pharma 13
Tianjin Zhongxin Pharma to Acquire 20% Stake in Chinese Medicine Unit 14
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Competitors 15
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employees 16
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tianjin Zhongxin Pharma To Form Two Joint Ventures 10
Tianjin Zhongxin Raises USD135.6 Million in Private Placement of Shares 11
Jiaxing Yun Shi Tai Yu Investment to Acquire 20% Stake in Tianjin Sinobioway Biomedicine from Tianjin Zhongxin Pharma 13
Tianjin Zhongxin Pharma to Acquire 20% Stake in Chinese Medicine Unit 14
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Competitors 15
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employees 16
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Other Locations 17
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Subsidiaries 17

List of Figures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endeavour Mining Corporation:企業の戦略・SWOT・財務情報
    Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • International Flavors & Fragrances Inc (IFF):企業の財務・戦略的SWOT分析
    International Flavors & Fragrances Inc (IFF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • DaVita Inc (DVA):医療機器:M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • mBio Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a …
  • Landsvirkjun hf:電力:M&Aディール及び事業提携情報
    Summary Landsvirkjun hf (Landsvirkjun) is a state-owned energy utility that conducts the generation and transmission of electricity in Iceland. It generates electricity through several renewable sources such as hydro, geothermal, and wind. Through subsidiaries, the company also offers telecommunicat …
  • Exchange Income Corporation:企業の戦略・SWOT・財務分析
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Meridian Bioscience Inc (VIVO)-医療機器分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial …
  • Dubai Islamic Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Swire Pacific Ltd:企業のM&A・事業提携・投資動向
    Swire Pacific Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swire Pacific Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Steel Authority Of India Ltd
    Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Zuivelcooperatie FrieslandCampina UA:企業の戦略的SWOT分析
    Zuivelcooperatie FrieslandCampina UA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • QRxPharma Ltd:企業の戦略的SWOT分析
    QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Nine Dragons Paper (Holdings) Limited:戦略・SWOT・企業財務分析
    Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆